KATHLEEN POSILLICO: Open Payments
NPI 1558080077 · BETHPAGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 37 payments from 16 companies in 2025. Trend: 2023 $90 · 2024 $641 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $291 |
| Novo Nordisk Inc | 4 | $72 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $50 |
| Tandem Diabetes Care, Inc. | 2 | $49 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $35 |
| Medtronic, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: JARDIANCE, Ozempic, ISTURISA, t:slim X2 Insulin Pump with Control-IQ, Cologuard Collection Kit, MINIMED 780G, GARDASIL 9, UNITHROID.
Industry payments across NY — which companies pay providers there.
